Using Registers to Study Effectiveness and Safety of Drugs

Using Registers to Study Effectiveness and Safety of Drugs

The article discusses the main aspects of registers use to evaluate the effectiveness and safety of drugs. It is noted that the results of the randomized clinical trials are currently constitute the highest level of evidence in medicine, but they have several limitations. Besides, in manycases evide...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. Yu. Drozdova, N. P. Kutishenko, M. L. Ginzburg
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	register randomized clinical trials observational studies effectiveness of drugs
Online Access:	https://klinitsist.abvpress.ru/Klin/article/view/47
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Observational studies and registers. Their quality and role in modern evidence-based medicine
by: S. Yu. Martsevich, et al.
Published: (2021-03-01)

New approaches in drug safety assessment based on information provided by doctors and patients in the register “PROFILE”
by: N. A. Dmitrieva, et al.
Published: (2020-01-01)

Efficacy, Safety and Long-term Outcomes of Nicorandil Use in Patients with Stable Ischemic Heart Disease According to the Results of Randomized and Observational Studies
by: Yu. V. Lukina, et al.
Published: (2019-11-01)

Randomised Clinical Trials and Observational Studies: the Ratio in the Hierarchy of Evidence of the Efficacy of Drugs
by: S. Yu. Martsevich, et al.
Published: (2016-11-01)

REGISTERS IN CARDIOLOGY: THEIR PRINCIPLES, RULES, AND REAL-WORD POTENTIAL
by: S. A. Boytsov, et al.
Published: (2013-02-01)

Development of Real-Time Surveillance for Serious Adverse Events in a Pragmatic Clinical Trial Using National Registers in Finland
by: Nieminen TA, et al.
Published: (2024-12-01)

Clinical Trials Evaluating Drug Therapy: Types, Reliability of Results, Place in Modern Evidence-Based Medicine
by: S. Yu. Martsevich, et al.
Published: (2021-05-01)

THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER)
by: M. L. Ginzburg, et al.
Published: (2015-09-01)

Registers of psoriatic arthritis. Literature review
by: A. D. Koltakova
Published: (2019-05-01)

EVALUATION OF THE CONFORMITY OF CARDIOVASCULAR THERAPY TO CURRENT CLINICAL GUIDELINES IN THE IMPROVEMENT OF OUTCOMES IN PATIENTS AFTER STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

ONCE AGAIN ABOUT THE HIERARCHY OF EVIDENCES IN MEDICINE OR WHETHER IT IS POSSIBLE TO CHOOSE THE MOST EFFECTIVE AND SAFE DRUG WITH THE HELP OF OBSERVATIONAL STUDIES
by: S. Y. Martsevich, et al.
Published: (2017-05-01)

DRUG SAFETY DATA COVERAGE IN MEDICAL LITERATURE
by: Yu. V. Muravyev, et al.
Published: (2015-09-01)

NEWS FROM THE ANNUAL CONGRESS OF EUROPEAN SOCIETY OF CARDIOLOGY (BARCELONA 2014): REALIZED AND UNREALIZED EXPECTATIONS
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

News of the European Society of Cardiology Congress (London, 28 August - 2 September 2015): old drugs may be better than the new ones
by: S. Yu. Martsevich, et al.
Published: (2015-11-01)

Registry or randomization – must it be evidence or could it be coincidence?
by: Radulova Olga, et al.
Published: (2024-06-01)

News of the Annual Congress of the European Society of Cardiology in Rome: the Obvious and Proven - it's not the Same Thing
by: S. Yu. Martsevich, et al.
Published: (2016-11-01)

DEVELOPING A REGISTER OF OUTCOMES OF CHRONIC CORONARY HEART DISEASE: CHD PROGNOSIS STUDY
by: S. N. Tolpygina, et al.
Published: (2013-02-01)

Why do we need "Real-World Data & Evidence", the new scientific electronic journal?
by: A. S. Kolbin
Published: (2021-08-01)

ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER)
by: Yu. V. Lukina, et al.
Published: (2016-06-01)

CLINICAL DEVELOPMENT STRATEGY FOR COPIES OF PREVIOUSLY REGISTERED DRUGS. PART 3. PROTOCOL OF CLINICAL TRIAL OF BIOEQUIVALENCE
by: K. A. Yatsenko, et al.
Published: (2019-01-01)

LIS-3 REGISTER OF THE ACUTE CORONARY SYNDROME: WHAT HAS CHANGED IN A "PORTRAIT" OF A PATIENT AND SHORT-TERM OUTCOMES OF THE DISEASE COMPARED TO LIS-1 REGISTER
by: S. Yu. Martsevich, et al.
Published: (2017-03-01)

Safety and immunogenicity of conjugate vaccine for typhoid (Vi-DT): Finding from an observer-blind, active-controlled, randomized, non-inferiority, phase III clinical trial among healthy volunteers
by: Dipesh Tamrakar, et al.
Published: (2024-12-01)

Registers as the basis for data collection and evidence building
by: A. V. Ivanov
Published: (2021-08-01)

Current landscape of dyslipidemia-related randomized clinical trials registered on the International Clinical Trials Registry Platform
by: Ling Pei, et al.
Published: (2025-05-01)

THE WAY OF ASSESSING THE ADHERENCE TO MODERN DRUG THERAPY CLINICAL GUIDELINES AIMED AT REDUCING THE RISK OF RECURRENT STROKE (ACCORDING TO THE LIS-2 REGISTER)
by: A. Yu. Suvorov, et al.
Published: (2015-09-01)

TRUST Study: Participation in Randomized Controlled Trials and Subsequent Adherence to Visiting Medical Institutions and Taking Medications in Patients with Cardiovascular Diseases. Part II. Assessment of the Quality of Therapy
by: N. O. Vasyukova, et al.
Published: (2020-12-01)

Assessment of adherence to medication and visits in healthcare facilities for cardiovascular patients who participated in international randomized controlled trials
by: N. O. Vasyukova, et al.
Published: (2019-12-01)

Could evidence-based medicine results be reproduced in real-world clinical practice?
by: S. Yu. Martsevich, et al.
Published: (2008-06-01)

THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

THE ANALYSIS OF LONG-TERM OUTCOMES AND ADHERENT TO TREATMENT IN PATIENTS AFTER MYOCARDIAL INFARCTION: KHABAROVSK REGISTER DATA
by: I. M. Davidovich, et al.
Published: (2017-07-01)

REGISTER OF PATIENTS AS AN EFFECTIVE METHOD OF DIAGNOSING PRIMARY IMMUNODEFICIENCIES
by: L. P. Sizyakina, et al.
Published: (2013-09-01)

Assessing the landscape of clinical and observational trials involving bioprinting: a scoping review
by: Yumi Briones, et al.
Published: (2025-02-01)

Role of Metformin in the Management of Colorectal Cancer: A Systematic Review
by: Norhan M. Abdelhafeez, et al.
Published: (2023-12-01)

PROLOG Study: decreasing cardiovascular disease risk in hypertensive patients by antihypertensive therapy
by: S. A. Shalnova, et al.
Published: (2005-08-01)

Stents in coronary heart disease patients: review of the studies available
by: L. A. Bokeriya, et al.
Published: (2009-02-01)

CHARACTERISTICS OF PATIENTS WITH CEREBRAL STROKE OR TRANSIENT ISCHEMIC ATTACK, INCLUDED INTO THE LIS-2 REGISTER (LYUBERTSY STUDY OF MORTALITY IN PATIENTS AFTER STROKE)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Registration of Medicines in the Soviet Control and Licensing System on the Example of the Cardiological Drug Trinitrolong
by: A. N. Petrenko, et al.
Published: (2021-03-01)

Occupational therapy and registered dietitian services to reduce fall risk among home delivered meal clients: a randomized controlled feasibility trial
by: Lisa A. Juckett, et al.
Published: (2025-05-01)

Medication Adherence: does Patient Participation in Randomized Clinical Trials Affect on it?
by: N. O. Vasyukova, et al.
Published: (2019-07-01)

REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION"
by: S. Yu. Martsevich, et al.
Published: (2016-06-01)